Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1993 1
1995 2
1996 2
1998 2
1999 3
2000 1
2001 3
2002 3
2003 4
2004 6
2005 3
2006 3
2007 2
2008 6
2009 4
2010 1
2011 3
2012 3
2013 6
2014 5
2015 5
2017 3
2018 5
2019 5
2020 6
2021 8
2022 9
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
How we treat chronic active Epstein-Barr virus infection.
Sawada A, Inoue M, Kawa K. Sawada A, et al. Int J Hematol. 2017 Apr;105(4):406-418. doi: 10.1007/s12185-017-2192-6. Epub 2017 Feb 16. Int J Hematol. 2017. PMID: 28210942 Review.
A severe hypercytokinemia and hemophagocytic syndrome, which may occur suddenly, often results in a fatal clinical course. At out institute, we have established a 3-step strategy, including allogeneic HSCT, for the treatment of CAEBV. ...
A severe hypercytokinemia and hemophagocytic syndrome, which may occur suddenly, often results in a fatal clinical course. At out ins …
PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection.
Song Y, Wang J, Wang Y, Wu L, You Y, Song D, Chen L, Meng G, He X, Cui T, Wang X, Yin Q, Wang Z. Song Y, et al. Clin Microbiol Infect. 2023 Jun;29(6):796.e7-796.e13. doi: 10.1016/j.cmi.2023.01.017. Epub 2023 Jan 24. Clin Microbiol Infect. 2023. PMID: 36702399 Free article.
As of the Feb 1, 2021 analysis cut-off date, 24 cases completed at least 3 courses and were assessed for efficacy. The overall response rate is 54.2% (13/24, 45.8% complete response; 8.3% partial response). ...The significant therapeutic effect and the different characteri …
As of the Feb 1, 2021 analysis cut-off date, 24 cases completed at least 3 courses and were assessed for efficacy. The overall respon …
Current research on chronic active Epstein-Barr virus infection in Japan.
Fujiwara S, Kimura H, Imadome K, Arai A, Kodama E, Morio T, Shimizu N, Wakiguchi H. Fujiwara S, et al. Pediatr Int. 2014 Apr;56(2):159-66. doi: 10.1111/ped.12314. Pediatr Int. 2014. PMID: 24528553 Review.
These patients have high EBV-DNA load in the peripheral blood and systemic clonal expansion of EBV-infected T cells or natural killer (NK) cells. Their prognosis is poor with life-threatening complications including hemophagocytic lymphohistiocytosis, organ failure, and ma …
These patients have high EBV-DNA load in the peripheral blood and systemic clonal expansion of EBV-infected T cells or natural killer (NK) c …
Chronic active Epstein-Barr virus infection involving gastrointestinal tract with hemophagocytic lymphohistiocytosis.
Shen K, Shuai X, Li J, Liu J, Liu T, Niu T, Ma H. Shen K, et al. Ann Hematol. 2023 Jan;102(1):45-53. doi: 10.1007/s00277-022-05081-6. Epub 2022 Dec 19. Ann Hematol. 2023. PMID: 36534145
CAEBV involving the gastrointestinal tract (GI CAEBV) is a rare condition with poor prognosis that may rapidly progress with hemophagocytic lymphohistiocytosis (HLH) and life-threatening complications such as GI bleeding and/or perforation. ...In this case series study, we …
CAEBV involving the gastrointestinal tract (GI CAEBV) is a rare condition with poor prognosis that may rapidly progress with hemophag …
Clinical Analysis of Chronic Active Epstein-Barr Virus Infection Involving the Gastrointestinal Tract.
Wei A, Li Z, Ma H, Zhang L, Zhang J, He L, Lian H, Zhang Q, Chen S, Xu J, Wang D, Liu W, Zhang R, Wang T. Wei A, et al. Pediatr Infect Dis J. 2023 Jan 1;42(1):13-19. doi: 10.1097/INF.0000000000003734. Epub 2022 Oct 11. Pediatr Infect Dis J. 2023. PMID: 36476520
The children's clinical manifestations, laboratory and ultrasound examinations, treatment and prognosis were observed. RESULTS: Seventy-two patients were enrolled in this study. ...The most common location of involvement was the colon. CAEBV with GI involvement had a poor …
The children's clinical manifestations, laboratory and ultrasound examinations, treatment and prognosis were observed. RESULTS: Seven …
Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome.
Okano M. Okano M. Crit Rev Oncol Hematol. 2002 Dec;44(3):273-82. doi: 10.1016/s1040-8428(02)00118-x. Crit Rev Oncol Hematol. 2002. PMID: 12467967 Review.
Since the late 1970s, a chronic undefined illness possibly associated with EBV infection, named such as severe chronic active EBV infection syndrome (SCAEBV), has been of interest due to its unique manifestations that often result in a poor prognosis. This review is an ove …
Since the late 1970s, a chronic undefined illness possibly associated with EBV infection, named such as severe chronic active EBV infection …
Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
Xiao H, Hu B, Luo R, Hu H, Zhang J, Kuang W, Zhang R, Li L, Liu G. Xiao H, et al. Virol J. 2020 Oct 29;17(1):166. doi: 10.1186/s12985-020-01409-8. Virol J. 2020. PMID: 33121509 Free PMC article.
BACKGROUND: Chronic active Epstein-Barr virus (CAEBV) infection is a type of lymphoproliferative disorder characterized by chronic or recurrent infectious mononucleosis (IM)-like symptoms, which can have less-frequent clinical presentations. The prognosis of CAEBV is poor, …
BACKGROUND: Chronic active Epstein-Barr virus (CAEBV) infection is a type of lymphoproliferative disorder characterized by chronic or recurr …
Recent Concise Viewpoints of Chronic Active Epstein-Barr Virus Infection.
Okano M. Okano M. Curr Pediatr Rev. 2015;11(1):5-9. doi: 10.2174/1573396311666150501002809. Curr Pediatr Rev. 2015. PMID: 25938379 Review.
Patients with CAEBV also may have various life-threatening conditions including hematological, neurological, pulmonary, cardiac, digestive tract, ocular and/or dermal disorders. Additionally, during the course of illness, they often develop hematological malignancies such …
Patients with CAEBV also may have various life-threatening conditions including hematological, neurological, pulmonary, cardiac, digestive t …
Chronic active Epstein-Barr virus infection.
Abe N, Fujieda Y. Abe N, et al. Blood. 2020 Oct 29;136(18):2090. doi: 10.1182/blood.2020008157. Blood. 2020. PMID: 33119764 Free article. No abstract available.
Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
Liu A, Takakuwa T, Luo WJ, Fujita S, Aozasa K. Liu A, et al. Cancer Sci. 2006 Jul;97(7):605-10. doi: 10.1111/j.1349-7006.2006.00226.x. Cancer Sci. 2006. PMID: 16827800 Free PMC article.
Nasal natural killer (NK)/T-cell lymphoma (NKTCL) and chronic active Epstein-Barr virus infection (CAEBV) are relatively frequent, especially in Asia, and are poor in prognosis. Both diseases are proliferative diseases of NK/T cells that show highly complicated karyotypes, …
Nasal natural killer (NK)/T-cell lymphoma (NKTCL) and chronic active Epstein-Barr virus infection (CAEBV) are relatively frequent, especiall …
99 results